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Abstract
Background: In the CT assessment of the carotid plaque, the analysis of the attenuation value is a fundamental
parameter in order to classify the type of the tissue that composes the plaque. The purpose of this paper is to
assess the intra-plaque attenuation variability in order to verify the potential reproducibility of HU measurements.
Methods: In this retrospective study, 68 consecutive patients (males 42; average age 64 ± 11 years) that underwent
CT of carotid arteries were included. Exams were performed before and after administration of contrast medium
and in each slice 4 different circular or elliptical ROIs (≥1 and ≤ 2 mm2) were traced and attenuation values were
recorded. Wilcoxon and Mann-Whitney test were used to test the differences between the ROI.
Results: A total of 192 slices were analysed. The average value of attenuation before contrast medium was 41.
591(SD 8.1) HU and 54.159 (SD 15.7) in post-contrast scan. Mann-Whitney test did not find statistically significant
difference among the ROI in the pre-contrast scan whereas a statistically significant differences was found in post-contrast
scan. Wilcoxon analysis showed a statistically significant difference (p value = 0.001) between pre and post-contrast
attenuation.
Conclusion: In conclusion, results of our study suggest that ROI sampling performed in the CT dataset acquired after
administration of contrast medium show significant degree of heterogeneity and a statistically significant differences
compared to the baseline measurement. This effect may be driven by a different amount of contrast acquisition in some
areas of the carotid artery plaque.
Background
Cerebrovascular ischemic events are the third leading
cause of death after acute myocardial infarction and can-
cer and represent the second cause of disability in the
Western world [1, 2]. A significant portion of the ische-
mic events have their cause in the embolization occurred
from the carotid artery [3, 4].
In the past years it was thought that the stenosis de-
gree was the leading parameter related to the patient’s
risk to develop cerebrovascular events [5] but in the last
decade several researches have demonstrated that the
plaque morphology and characteristics play a fundamen-
tal role in the development of embolic cascade [6, 7].
Therefore identification of carotid artery features that
are associated with plaque vulnerability is extremely
important in order to correctly stratify the risk of occur-
rence of cerebrovascular events [8, 9] that’s why several
imaging techniques are trying to identify those charac-
teristics [10, 11].
Ultrasonography (US) is nowadays considered the
first-line exam [12] but in most of centres Magnetic Res-
onance Imaging (MRI) or Computed Tomography (CT)
are required to confirm or to rule out the presence of
pathological stenosis and\or plaque’s characteristics re-
lated to the vulnerability [13, 14]. MRI offers, other than
the potentiality of quantify the degree of stenosis, the
opportunity to identify the presence of intra-plaque-
hemorrhage (IPH), lipid-rich necrotic core (LRNC) as well
as the status of the fibrous cap [15, 16].
In the assessment of the carotid arteries, CT is a fre-
quently used technique because of the wide availability,
the rapid time execution and its potentiality to identify
some features related to the plaque vulnerability [17–19].
In the CT assessment of the carotid plaque the analysis
* Correspondence: lucasaba@tiscali.it
1Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di
Cagliari – Polo di Monserrato, s.s. 554 Monserrato, Cagliari 09045, Italy
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Saba et al. Neurovascular Imaging  (2016) 2:12 
DOI 10.1186/s40809-016-0023-4
of the attenuation value is a fundamental parameter in
order to classify the type of the tissue that composes
the plaque [20].
The purpose of this paper is to assess the intra-plaque
attenuation variability in order to verify the potential re-
producibility of HU measurements.
Methods
Study design and patient population
In this retrospective study, 68 consecutive patients (males
42, females 16; median age 64 ± 11 years, age range 44–82
years) that underwent CTA between January 2012 and
May 2012 were included. The IRB approval was obtained
and because of the retrospective nature of the analysis
patient’s consent was waived.
In our Hospital CTA is performed after ultrasonography
that is used as exam to rule-out significant atherosclerotic
disease of the supra-aortic vessels. In particular CTA is
performed when a) carotid sonography shows a patho-
logical stenosis (>50% according to the NASCET criteria
[21]) or plaque’s features related to plaque vulnerability
(such as ulcers of irregular luminal morphology) b) sonog-
raphy cannot adequately assess degree of stenosis and pla-
que’s characteristics because of anatomical conditions.
CTA technique
None of the patients included in this research had any
contraindications to iodinated contrast media. CTA was
performed using a 16-multi-detector row CT system
(Philips Brilliance, Eindhoven, Netherlands). Acquisitions
were performed from the aortic arch to the circle of Willis
before and after administration of contrast medium. Bolus
tracking technique was used in all cases. The ROI trigger
threshold was placed into the aortic arch and six seconds
after the beginning of the i.v. administration of 80 ml of
pre-warmed contrast medium (Ultravist 370; Schering,
Berlin, Germany) into median cubital vein (flow rate of 5
ml/s) the monitor scanning began. The trigger threshold
was set at + 80 HU above the baseline. Four seconds after
having reached the threshold the angiographic phase
began. CT technical parameters were: matrix 512×512,
field of view 14–19 cm; slice thickness 0.6 mm, interval
0.3 mm, 180–220 mAs; 120–140 kV. C-filter algorithm of
reconstruction was applied.
Plaque analysis
The window parameters (center/level) was set at
W850:L300 according to Saba et al [21] and in the
first phase the observer (XX, 12 years of experience in
vascular imaging) analysed the dataset acquired after
administration of contrast material. The carotid artery
plaque was identified and for each slice 4 different cir-
cular or elliptical ROIs were traced. The 4 ROI were
exactly the same in each slice and their dimension was
variable ≥ 1 and ≤ 2 mm2 in the different slices. When
small cluster of calcium were identified, these are avoided
in the ROI tracings. We considered 2 main exclusion cri-
teria 1) calcified plaques 2) presence of artefacts (move-
ment or dental artefacts). In the second phase the basal
scan were assessed. The observers identified the same slice
correspondent to the angiographic phase and the same
ROIs (for locations and dimension) used in the angio-
graphic phase were applied in the slices (Fig. 1).
At the end of the analysis the ROI were grouped ac-
cording to their HU value from the lower to the higher
values and ROI 1 represents the lower HU values
whereas ROI 4 the higher.
Statistical analysis
In this study the normality of each continuous variable
group was tested using the Kolmogorov-Smirnov Z test
and appropriate tests for Gaussian or non-Gaussian values
were selected. For Gaussian values, continuous data were
described as the mean value ± SD whereas for non-gaussian
values median values were given. Wilcoxon test was applied
to test the difference of attenuation of the ROIs traced be-
fore and after administration of contrast material whereas
the Mann-Whitney test was used to test the differences be-
tween the ROI. A p value < 0.05 was regarded to indicate
statistical significance association and all values were
calculated using a two-tailed significance level. R soft-
ware (www.r-project.org) was employed for statistical
analyses.
Results
Of the 136 carotid arteries that were imaged with CTA,
sixteen carotid arteries were excluded because no evi-
dence of plaque was found. Other 41 carotid arteries
were excluded because their plaque was heavily calcified
and other 12 because of the presence of artefacts (move-
ments n = 6 and dental artefacts n = 6). The remaining
67 carotid artery plaques were analysed and 192 slices
were found where it was possible to trace 4 ROIs with
area between 1 and 2 mm2.
In the Table 1 are summarized the results of the at-
tenuation values of the four ROIs in the basal and post-
contrast phase. The average value of attenuation before
contrast medium was 41.591 HU (SD 8.1) and 54.159
(SD 15.7) after its administration. The average value of
the ROI used was 1.532 mm2 (SD 0.163).
By comparing the attenuation values among the four
different ROIs (summarized in the Table 2) we found
that in the basal scan no statistic differences among the
four ROIs was found whereas in the scan performed
after contrast material in most of cases there were differ-
ence among the ROI values. Standard deviation analysis
was also performed (summarized in the Table 3). In the
Fig. 2 is given a box-plot that shows the attenuation
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values of the ROI and the Standard Deviations before
and after administration of contrast material.
Wilcoxon analysis was used to assess the difference of
attenuation before and after administration of contrast
material. By comparing the overall attenuation of the
ROI of the plaques before and after administration of
contrast medium we found a statistically significant dif-
ference (p value = 0.001).
Discussion
Attenuation analysis of carotid artery plaque represents
an important criterion for the identification of plaque’s
vulnerability because some types of tissue (fatty ones)
are associated with an increased risk [22] of cerebro-
vascular events whereas others (calcified tissues) are
associated with a reduced risk [23]. In this study our
purpose was to assess the intra-plaque attenuation
variability in order to verify the potential reproducibility of
HU measurements and to assess the polymorphism of the
plaque.
Our analysis relies to previous histopathological stud-
ies that have been demonstrated that multiple type of
tissues are present in the carotid artery plaques [24, 25]
and that this features can be visible also in the CT
images.
We excluded from the ROI tracings those areas where
small calcium deposits or cluster of calcium were visible
and we considered as exclusion criteria for a slice the
presence of heavily calcified plaques (that determines HU
values usually very high up to 800–1000). Nowadays it is
extremely important to obtain information that allows to
identify and distinguish the fatty plaque (components)
from the mixed plaques (components).
Moreover the structure of the carotid artery plaque,
when big calcification are present, is characterized by the
peripheral location of the calcium components with the
Fig. 1 In panel a and b the right carotid plaque of a 61 years old male patient is given. The 4 ROI are visible in the pre contrast (a) and
post-contrast scan (b). In panel c and d the left carotid plaque of a 68 years old female patient is given. The 4 ROI are visible in the pre
contrast (c) and post-contrast scan (d). The white arrow indicates the lumen of the carotid artery
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lipid components close to the intima layer and it is this part
of the plaque that may evolve to rupture and embolization.
By comparing the attenuation values among the four
different ROIs the Mann-Whitney test did not show
statistical differences among the four ROIs in the basal
scan, whereas in the scan performed after contrast ma-
terial administration in most cases there were difference
among ROI values. This is an interesting point because
shows 2 different types of information: 1) in the basal
scan there are some differences (Table 1) but these are
not statistically significant 2) After contrast material the
differences between the ROI are statistically significant.
These results indicate that ROI sampling for the HU
assessment of the carotid artery plaque in the scan ac-
quired after administration of contrast material can pro-
duce heterogeneous results according to the position of
the ROI in the plaque and that the values are statistically
different in the different part of the plaque. Moreover
this heterogeneity is mainly due to the effect of the con-
trast material, as demonstrated by the fact that in the
basal scan these differences are not significant whereas
after contrast medium become statistically significant.
Therefore, the difference of attenuation identified in
the ROI may represent a difference of contrast material
Table 1 Summary values of attenuation (measured in HU) of the ROIs before and after administration of contrast medium (with the
Standard Deviation)
Mean SD Minimum Maximum 2.5–97.5 P Normal Distr.
ROI 1 basal 33.818 11.0074 14 49 14.000–49.000 0.3899
ROI 1 contrast 40.273 9.1879 24 51 24.000–51.000 0.6966
ROI 2 basal 41.364 7.5534 28 52 28.000–52.000 0.5753
ROI 2 contrast 51.273 10.2868 31 62 31.000–62.000 0.0512
ROI 3 basal 41.909 11.5884 27 57 27.000–57.000 0.0872
ROI 3 contrast 56.273 13.8859 31 72 31.000–72.000 0.3031
ROI 4 basal 49.273 20.7079 28 99 28.000–99.000 0.0254
ROI 4 contrast 68.818 19.0778 43 101 43.00–101.000 0.8457
SD ROI 1 basal 7.545 2.1616 5 11 5.000–11.000 0.5274
SD ROI 1 contrast 10.364 4.081 5 20 5.000–20.000 0.0547
SD ROI 2 basal 11.818 4.3547 4 17 4.000–17.000 0.6073
SD ROI 2 contrast 17.091 9.7719 5 34 5.000–34.000 0.6494
SD ROI 3 basal 7.909 2.0226 5 11 5.000–11.000 0.3265
SD ROI 3 contrast 10.091 4.6574 4 18 4.000–18.000 0.6571
SD ROI 4 basal 10.455 4.5905 5 20 5.000–20.000 0.5176
SD ROI 4 contrast 15.545 6.1703 9 25 9.000–25.000 0.157
Table 2 Mann-Whitney analysis of the ROI attenuation values
(p values are given)
Basal Attenuation values
ROI 1 ROI 2 ROI 3 ROI 4
ROI 1 x 0,1006 0,2122 0,078
ROI 2 x 0,695 0,524
ROI 3 x 0,722
ROI 4 x
Post contrast Attenuation values
ROI 1 ROI 2 ROI 3 ROI 4
ROI 1 x 0,0086* 0,0053* 0,0008*
ROI 2 x 0,1311 0,0488*
ROI 3 x 0,0115*
ROI 4 x
*statistically significant difference
Table 3 Mann-Whitney analysis of the Standard Deviation of
ROI attenuation values (p values are given)
Basal Attenuation values
ROI 1 ROI 2 ROI 3 ROI 4
ROI 1 x 0,0196 0,691 0,1062
ROI 2 x 0,0351 0,3579
ROI 3 x 0,1779
ROI 4 x
Post contrast Attenuation values
ROI 1 ROI 2 ROI 3 ROI 4
ROI 1 x 0,1306 0,818 0,0562
ROI 2 x 0,071* 0,9215
ROI 3 x 0,0417
ROI 4 x
*statistically significant difference
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acquisition in different areas of the plaque. These re-
sults are in line with previously published papers that
have demonstrated how carotid artery plaques shows
enhancement after administration of contrast material
[26–29]. Therefore, the attenuation value of the carotid
artery plaque after administration of contrast material
seems to represent not only the plaque type but also
the amount of contrast material that enters in some
areas of the plaques that is mainly due to the neovascu-
larization or to the rupture of the fibrous cap [9, 30].
This approach suggests that for the HU quantification
of the tissue type the only pre-contrast CT should be
performed and not the one after contrast material. This
finding is concordant with a the study results of a paper
published by Park et al [12] in 2012 where the authors
demonstrated in a small cohort of carotid arteries (n =
43) that is the attenuation value obtained in he pre-
contrast scan that is associated with the cerebrovascu-
lar symptoms whereas the attenuation values obtained
after contrast medium do not show statistically signifi-
cant association with the cerebrovascular symptoms.
Further analysis are needed to assess if the basal scan
may be helpful to stratify the risk to develop cerebro-
vascular events.
We also assessed, using the Wilcoxon analysis, the glo-
bal variation of attenuation of the plaque’s ROI before
and after contrast medium (basal value = 41.591 HU;
contrast value = 54.159) and we found a statistically sig-
nificant difference (p value = 0.001).
Conclusion
In conclusion, results of our study suggest that the ROI
sampling performed in the CT dataset acquired after ad-
ministration of contrast medium show significant degree
of heterogeneity and that the ROI have a statistically
significant differences. This effect may be driven by a
different amount of contrast acquisition in some areas
of the carotid artery plaque.
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